OBJECTIVE: Congestive heart failure (CHF) has been associated with insulin resistance, but few studies have examined its relationship with metabolic syndrome (MetS). Little is known about whether insulin resistance explains the association between MetS and CHF. DESIGN: Population-based, cross-sectional surveys. SETTING: Third National Health and Nutrition Examination Survey (NHANES III). PARTICIPANTS: Data from 5549 men and non-pregnant women aged > or =40 years in NHANES III were analysed. RESULTS: About 4% of men and 3% of women had CHF between 1988 and 1994 in the US. The age-adjusted prevalence of CHF was significantly higher in African Americans (4.1%), in Mexican Americans (8.5%) and in those of other ethnic origin (6.7%) than in white people (2.5%). People with MetS had nearly twice the likelihood of self-reported CHF (adjusted odds ratio 1.8; 95% confidence interval 1.1 to 3.0) after adjustment for demographic and conventional risk factors such as sex, ethnicity, age, smoking, total cholesterol, left ventricular hypertrophy, and probable or possible myocardial infarction determined by electrocardiography. However, this association was attenuated after further adjustment for insulin resistance as measured by the homoeostasis model assessment (HOMA). >90% of the association between MetS and CHF was explained by the HOMA. CONCLUSIONS: MetS was associated with about a twofold increased likelihood of self-reported CHF and it may serve as a surrogate indicator for the association between insulin resistance and CHF.
OBJECTIVE:Congestive heart failure (CHF) has been associated with insulin resistance, but few studies have examined its relationship with metabolic syndrome (MetS). Little is known about whether insulin resistance explains the association between MetS and CHF. DESIGN: Population-based, cross-sectional surveys. SETTING: Third National Health and Nutrition Examination Survey (NHANES III). PARTICIPANTS: Data from 5549 men and non-pregnant women aged > or =40 years in NHANES III were analysed. RESULTS: About 4% of men and 3% of women had CHF between 1988 and 1994 in the US. The age-adjusted prevalence of CHF was significantly higher in African Americans (4.1%), in Mexican Americans (8.5%) and in those of other ethnic origin (6.7%) than in white people (2.5%). People with MetS had nearly twice the likelihood of self-reported CHF (adjusted odds ratio 1.8; 95% confidence interval 1.1 to 3.0) after adjustment for demographic and conventional risk factors such as sex, ethnicity, age, smoking, total cholesterol, left ventricular hypertrophy, and probable or possible myocardial infarction determined by electrocardiography. However, this association was attenuated after further adjustment for insulin resistance as measured by the homoeostasis model assessment (HOMA). >90% of the association between MetS and CHF was explained by the HOMA. CONCLUSIONS: MetS was associated with about a twofold increased likelihood of self-reported CHF and it may serve as a surrogate indicator for the association between insulin resistance and CHF.
Authors: G Paolisso; M R Tagliamonte; M R Rizzo; A Gambardella; P Gualdiero; D Lama; G Varricchio; S Gentile; M Varricchio Journal: Am J Cardiol Date: 1999-05-01 Impact factor: 2.778
Authors: Ann Marie McNeill; Wayne D Rosamond; Cynthia J Girman; Sherita Hill Golden; Maria I Schmidt; Honey E East; Christie M Ballantyne; Gerardo Heiss Journal: Diabetes Care Date: 2005-02 Impact factor: 19.112
Authors: Steven E Stern; Ken Williams; Eleuterio Ferrannini; Ralph A DeFronzo; Clifton Bogardus; Michael P Stern Journal: Diabetes Date: 2005-02 Impact factor: 9.461
Authors: Giacomo Levantesi; Alejandro Macchia; RosaMaria Marfisi; Maria G Franzosi; Aldo P Maggioni; Gian L Nicolosi; Carlo Schweiger; Luigi Tavazzi; Gianni Tognoni; Franco Valagussa; Roberto Marchioli Journal: J Am Coll Cardiol Date: 2005-07-19 Impact factor: 24.094
Authors: R T Zamanian; G Hansmann; S Snook; D Lilienfeld; K M Rappaport; G M Reaven; M Rabinovitch; R L Doyle Journal: Eur Respir J Date: 2008-12-01 Impact factor: 16.671
Authors: Corinna Koebnick; Ning Smith; Karl Huang; Mayra P Martinez; Heather A Clancy; Lawrence H Kushi Journal: Ann Epidemiol Date: 2012-07-04 Impact factor: 3.797
Authors: Carlo Selmi; M Eric Gershwin; Keith D Lindor; Howard J Worman; Ellen B Gold; Mitchell Watnik; Jessica Utts; Pietro Invernizzi; Marshall M Kaplan; John M Vierling; Christopher L Bowlus; Marina G Silveira; Ilaria Bossi Journal: Hepatology Date: 2007-12 Impact factor: 17.425
Authors: Salvatore La Carrubba; Maria Chiara Todaro; Concetta Zito; Francesco Antonini-Canterin; Ines Paola Monte; Pio Caso; Paolo Colonna; Cesare de Gregorio; Antonio Pezzano; Frank Benedetto; Giovanni Di Salvo; Scipione Carerj; Vitantonio Di Bello Journal: J Cardiovasc Echogr Date: 2013 Oct-Dec
Authors: João Pedro Ferreira; Subodh Verma; David Fitchett; Anne Pernille Ofstad; Sabine Lauer; Isabella Zwiener; Jyothis George; Christoph Wanner; Bernard Zinman; Silvio E Inzucchi Journal: Cardiovasc Diabetol Date: 2020-11-26 Impact factor: 9.951